Sychedelic Raises $3.5M for AI Mental Wellness Headphones
By Sivam
Sychedelic secures $3.5M seed funding to develop AI-powered headphones for mental wellness, utilizing biofeedback and neuromodulation. Global Kickstarter launch planned.
Sychedelic Raises $3.5 Million Seed Funding for AI-Powered Mental Wellness Headphones
Wearable technology startup Sychedelic has successfully closed a $3.5 million seed funding round, securing capital from prominent investors including Cultadvisors LLP, TurboStart, Ideabaaz, and Praveek Ventures, alongside participation from several angel investors. This significant financial injection is earmarked for crucial growth initiatives, including scaling manufacturing operations, bolstering marketing efforts, expanding research and development capabilities, and supporting an upcoming global Kickstarter launch planned for June 2026.
From Neuphony to Sychedelic: A Pivot Towards Advanced Mental Wellness
Founded in 2020 by Ria Rustagi and Bhavya Madan, the Delhi NCR-based company initially operated under the name Neuphony. In its early phase, the startup focused on developing EEG-based neurofeedback headbands designed to monitor brain activity and various mental wellness indicators. Recognizing a growing market demand and technological advancements, the company strategically pivoted and rebranded as Sychedelic to concentrate on creating innovative headphones. These new devices are engineered to reduce stress, enhance focus, and improve sleep quality by integrating real-time biofeedback with advanced neuromodulation technologies.
Innovative Technology Driving Mental Wellness
Sychedelic’s proprietary headphones represent a significant technological leap in the wearable healthtech sector. The devices incorporate photoplethysmography (PPG) sensors, a non-invasive optical sensing method used to detect blood flow variations, alongside adaptive audio features and transcranial direct current stimulation (tDCS) technology. This sophisticated combination allows the headphones to monitor users’ stress levels and cognitive states in real-time, enabling immediate, personalized interventions. The company has received CDSCO (Central Drugs Standard Control Organisation) approval and has filed global patent applications for its unique technology, positioning it as a pioneer in closed-loop neuromodulation wearable systems that dynamically adjust stimulation based on live biometric feedback.
Global Operations and Early User Feedback
The startup currently maintains a dual operational presence in India and the United States, with a dedicated entity in Delaware and a science advisor based in New York, complemented by freelance marketing professionals managing its global outreach. Sychedelic has engaged over 100 early users in the past six months, whose feedback has been instrumental in refining both the hardware design and the adaptive algorithms of their products. This iterative development process, informed by real-world usage, underscores the company’s commitment to user-centric innovation.
Market Landscape and Future Outlook
The funding arrives at a pivotal moment for the wearable healthtech market, which is rapidly evolving beyond basic fitness tracking to encompass specialized solutions for mental wellness and sleep optimization. Sychedelic faces competition from other notable players in this emerging space, including Sputnik Brain and Mave Health. The increasing consumer interest in advanced mental wellness devices, coupled with substantial market growth projections—the Indian smart wearables market is anticipated to reach $10.26 billion by 2031—positions Sychedelic for significant potential in the coming years.